Connor, Clark & Lunn Investment Management (CC&L)’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
|
|||||
|
2025
Q1 | $8.87M | Buy |
|
|||||
|
2024
Q4 | $7.43M | Sell |
|
|||||
|
2024
Q3 | $7.35M | Buy |
|
|||||
|
2024
Q2 | $3.88M | Buy |
|
|||||
|
2024
Q1 | $3.21M | Buy |
|
|||||
|
2023
Q4 | $2.59M | Sell |
|
|||||
|
2023
Q3 | $2.6M | Sell |
|
|||||
|
2023
Q2 | $4.47M | Buy |
|
|||||
|
2023
Q1 | $6.23M | Buy |
|
|||||
|
2022
Q4 | $5.15M | Sell |
|
|||||
|
2022
Q3 | $6.08M | Buy |
|
|||||
|
2022
Q2 | $5.76M | Buy |
|
|||||
|
2022
Q1 | $6.08M | Buy |
|
|||||
|
2021
Q4 | $7.15M | Buy |
|
|||||
|
2021
Q3 | $4.08M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $338K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $378K | Sell |
|
|||||
|
2018
Q2 | $643K | Sell |
|
|||||
|
2018
Q1 | $890K | Sell |
|
|||||
|
2017
Q4 | $852K | Sell |
|
|||||
|
2017
Q3 | $1.36M | Sell |
|
|||||
|
2017
Q2 | $1.4M | Buy |
|
|||||
|
2017
Q1 | $560K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $373K | Sell |
|
|||||
|
2016
Q1 | $1.5M | Sell |
|
|||||
|
2015
Q4 | $2.88M | Buy |
|
|||||
|
2015
Q3 | $2.94M | Sell |
|
|||||
|
2015
Q2 | $5.08M | Sell |
|
|||||
|
2015
Q1 | $4.38M | Buy |
|
|||||
|
2014
Q4 | $1.71M | Buy |
|
|||||
|
2014
Q3 | $781K | Buy |
|